Al menos una quinta parte de la población mundial podría no tener acceso a una vacuna contra el COVID-19 hasta 2022, según un estudio, que destaca que los países ricos ya reservaron más de la mitad de las dosis en principio disponibles para 2021. (Fuente: AFP)
:quality(75)/cdn.jwplayer.com/v2/media/3WyUFt0y/poster.jpg)
:quality(75)/dvgnzpfv30f28.cloudfront.net/12-16-2020/t_bc66aea9b23442958a2a4453696cf225_name_file_640x360_600_v3_.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/lcJYjzTu/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/Z4LZE7C76VFCRBJT5BC3YMLWMU.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/nrPzJ4gj/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/UZD65mZH/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/avGXOsZ4/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/UZ33FKQGUZAUBIDC7WT3XC2MLY.png)
:quality(75)/cdn.jwplayer.com/v2/media/jvOyeiFV/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/lcJYjzTu/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/WVUXO4EV2ZFZVDLFIKR2LU5PZU.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/whZALDRw/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/QEB3P7MEVBEAHMB3FUBL27TTWY.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/3WyUFt0y/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/Z4LZE7C76VFCRBJT5BC3YMLWMU.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/nrPzJ4gj/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/NLuiEsTt/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/1QmqNzz7/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/MZVlh9r6/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/E4Quiira/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/FJHXJROFRFFQHON3TLN4PCGX2E.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/koNs9MA2/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/6bLTGi5d/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/KgeU8b6Q/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/a6mwPQ4X/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/X3PAJUVAAFHRXHUYV5TON7UAAY.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/5MX44LCM7BFEVHZQU33WFPMZFE.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/aIjZ5WWB/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/juAVPNx9/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/c0S03whF/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/azLadx4o/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/FQ5XSTUGQ5DI3DYDC3MUSLQL6A.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/9a1H4G0a/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/QYPNFGK56RE7FB6OYBZFBZOR6M.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/8j1uxDqb/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/ZxUTUGfS/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/yOEdb2ys/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/JW2JBE7IBZEY5NR2VH4KVTPGZ4.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/42WZKDIDGVA6VKQDF75376W2CA.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/ENCJ6JEIFZHT5E6UXK3KZ5RCUU.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/UZ27WLDNBFBCPCMLG42DQCNJYA.png)